Drug development for neurological disorders has been proven to be very difficult and unsuccessful. At Neurospector, we are at the forefront of revolutionizing drug development through cutting-edge research using predictive human neuron disease models and advanced read-outs of neuronal functioning. Our mission is to harness the power of translational neuroscience to test new treatments for neurological disorders and improve the quality of life for millions worldwide.

We have optimized our culture procedures to grow functionally mature excitatory and inhibitory cortical human neurons, as well as human motorneurons. We work with monocultures and co-cultures of human neurons with astrocytes or human muscle. All our human neuron cultures go through extensive quality control.

With more than 20 years of experience in measuring neuronal communication, we have developed an extensive library of functional read-outs, including live microscopy of neuronal network activity and synaptic activity, electrophysiology, intracellular vesicle trafficking and secretion and morphological parameters.

We offer customized projects for compounds screening and validation, target discovery or the development of novel predictive disese models. We focus on neurodevelopmental, neurodegenerative and psychiatric disorders, or defects in neuronal communication or intracellular trafficking.